K43
Conditions
Interventions
Group 1: Verum group:
Performance of the oblique subcostal transverse abdominal plane block under general anesthesia prior to surgical incision using 2 x 30mL ropvacaine 0.35%
Group 2: Placebo group:
Sponsors
Klinik für Anästhesie und Intensivmedizin Diakonie-Klinikum Stuttgart
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Presence of an abdominal wall hernia which is to be treated surgically by means of an open hernioplasty using the sublay technique • Consentable patient • Age > 18 years • Provided information and consent
Exclusion criteria
Exclusion criteria: • Refusal to participate in the study • Regular use of opioids • Known chronic pain symptoms • Infections in the abdominal wall • Scarring changes in the abdominal wall that could prevent intrafascial spread of the local anesthetic • Pregnancy • Presence of a contraindication to ropivacaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the postoperative consumption of intravenously administered morphine during the first 48 hours after surgery. This is quantified using patient-controlled analgesia using specialized syringe pumps. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpoints: - NRS values on the evening of the operation, in the morning and evening of the first and second postoperative day - PONV score on the evening of the operation, in the morning and evening of the first and second postoperative day (subjective scale 0-3) - Postoperative length of stay in the recovery room in minutes - postoperative length of stay in hospital in days - overall satisfaction on the evening of the operation, in the morning and evening of the first and second postoperative day (subjective scale 0-10) | — |
Countries
Germany
Contacts
Public ContactRainer Meierhenrich
Klinik für Anästhesie und Intensivmedizin Diakonie-Klinikum Stuttgart
Outcome results
None listed